Skip to main content
OpenTrials

Clinical trial condition

Colon Adenocarcinoma

Explore clinical trials studying Colon Adenocarcinoma. Study availability and eligibility vary by location and protocol.

42 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Colon Adenocarcinoma trial results

Active, not recruiting

Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer

NCT04963283

Conditions
Colon Adenocarcinoma, Colon Cancer, Colonic Diseases, +17 more
Locations
  • University of Colorado Hospital Aurora, Colorado, United States
  • UCHealth Memorial Hospital Central Colorado Springs, Colorado, United States
  • UCHealth Harmony Campus Fort Collins, Colorado, United States
  • UCHealth Family Medicine - Greeley Greeley, Colorado, United States
View Trial Details
Active, not recruiting

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

NCT04068103

Conditions
Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 957 locations
View Trial Details
Completed

Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

NCT00217737

Conditions
Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +12 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
View all 928 locations
View Trial Details
Completed

S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

NCT03365882

Conditions
Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +29 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 798 locations
View Trial Details
Completed

Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer

NCT02368886

Conditions
Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +19 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Illinois CancerCare-Peoria Peoria, Illinois, United States
View all 22 locations
View Trial Details

Related conditions